StockMarketWire.com - Scancell Holdings, which develops immunotherapies for the treatment of cancer, said it would present at separate conferences in London and Shanghai.
Chief executive Cliff Holloway would present an overview of the company at the LSX conference in London on 13 November.
In addition, current director and previous CEO Richard Goodfellow would present at the BioCentury-BayHelix China Healthcare Summit in Shanghai, held on 13-14 November.
At 9:49am: [LON:SCLP] Scancell Holdings PLC share price was +0.15p at 8.9p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.